Back

Latent Class Analysis Identifies Pulmonary Function Trajectory Phenotypes in Lung Transplant Recipients with Chronic Allograft Dysfunction

Neely, M.; Wojdyla, D. M.; Hong, H.; Wang, P.; Anderson, M. R.; Arroyo, K.; Belperio, J.; Benvenuto, L.; Budev, M.; Combs, M.; Dhillon, G.; Hsu, J. Y.; Kalman, L.; Martinu, T.; McDyer, J.; Oyster, M.; Pandya, K.; Reynolds, J. M.; Rim, J. G.; Roe, D. W.; Shah, P. D.; Singer, J. P.; Singer, L.; Snyder, L. P.; Tsuang, W.; Weigt, S. S.; Christie, J. D.; Palmer, S. M.; Todd, J.

2026-04-23 transplantation
10.64898/2026.04.22.26351501 medRxiv
Show abstract

BackgroundWe aimed to identify data-driven FEV1 trajectory phenotypes post-chronic lung allograft dysfunction (CLAD), relate these phenotypes to patient factors and future graft loss, and develop a classification approach for prospective patients. MethodsWe studied adult first lung recipients with probable CLAD from two prospective multicenter cohorts: CTOT-20 (n=206) and LTOG (n=1418). FEV1 trajectories over the first nine months post-CLAD were characterized using joint latent class mixed models, jointly modelling time-to-graft loss to account for informative censoring. Models were fit independently in both cohorts and also only among LTOG bilateral recipients. A classification and regression tree (CART) model was derived in LTOG bilateral recipients and applied to CTOT-20 bilateral recipients. FindingsFour distinct early FEV1 trajectory classes were identified in CTOT-20, with large differences in nine-month graft loss (72{middle dot}3%, 31{middle dot}1%, 2{middle dot}2%, 0%). In LTOG, similar trajectory patterns were reproduced, with an additional class demonstrating early post-CLAD FEV1 improvement. Among bilateral recipients, trajectory classes showed a clear risk gradient, including a high-risk class with 100% graft loss and a low-risk class with no early graft loss. A CART model incorporating clinical and spirometric variables demonstrated good discrimination in LTOG bilateral recipients (multiclass AUC 0{middle dot}85) and consistent class assignment and trajectory patterns when applied to CTOT-20. InterpretationWe identified reproducible, clinically meaningful early post-CLAD FEV1 trajectory phenotypes with differential graft loss risk. These phenotypes and a pragmatic classification tool may support risk stratification, trial enrichment, and improved prognostication for patients and clinicians. FundingNational Institutes of Health, Cystic Fibrosis Foundation

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
The Journal of Heart and Lung Transplantation
10 papers in training set
Top 0.1%
18.4%
2
The Journal of Infectious Diseases
182 papers in training set
Top 0.2%
10.0%
3
PLOS ONE
4510 papers in training set
Top 24%
7.1%
4
Annals of Internal Medicine
27 papers in training set
Top 0.1%
6.3%
5
Transplantation
13 papers in training set
Top 0.1%
6.3%
6
JAMA Network Open
127 papers in training set
Top 0.5%
6.2%
50% of probability mass above
7
Journal of Clinical Investigation
164 papers in training set
Top 0.5%
4.8%
8
American Journal of Transplantation
15 papers in training set
Top 0.1%
4.8%
9
European Respiratory Journal
54 papers in training set
Top 0.5%
3.5%
10
JCI Insight
241 papers in training set
Top 1%
3.5%
11
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.3%
3.0%
12
Journal of the American Society of Nephrology
52 papers in training set
Top 0.3%
2.4%
13
Scientific Reports
3102 papers in training set
Top 53%
1.9%
14
Frontiers in Public Health
140 papers in training set
Top 4%
1.9%
15
Nature Communications
4913 papers in training set
Top 53%
1.6%
16
Journal of Clinical Medicine
91 papers in training set
Top 4%
1.3%
17
Kidney360
22 papers in training set
Top 0.4%
1.3%
18
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.6%
0.9%
19
npj Regenerative Medicine
21 papers in training set
Top 0.2%
0.9%
20
Microbiology Spectrum
435 papers in training set
Top 5%
0.9%
21
BMJ Open
554 papers in training set
Top 13%
0.7%
22
Frontiers in Immunology
586 papers in training set
Top 8%
0.7%
23
Circulation: Heart Failure
14 papers in training set
Top 0.5%
0.7%